Quest Diagnostics Inc (DGX) stock
DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/308% above fair value
$259.69+3.34 (+1.30%)
Close on Nov 18, 2026Market cap $28.57BP/E 25.9Yield –
Quest Diagnostics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Quest Diagnostics's revenue for the twelve months ending Sep 30, 2026 was $11.84B, up 9.1% year over year. For fiscal 2025 it was $11.04B, up 11.8% from the year before. Over ten years it grew 3.9% a year on average. The highest annual figure on record is $11.04B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.04B | +11.8% |
| FY2024 | Dec 31, 2024 | $9.87B | +6.7% |
| FY2023 | Dec 31, 2023 | $9.25B | -6.4% |
| FY2022 | Dec 31, 2022 | $9.88B | -8.4% |
| FY2021 | Dec 31, 2021 | $10.79B | +14.3% |
| FY2020 | Dec 31, 2020 | $9.44B | +22.1% |
| FY2019 | Dec 31, 2019 | $7.73B | +2.6% |
| FY2018 | Dec 31, 2018 | $7.53B | +1.7% |
| FY2017 | Dec 31, 2017 | $7.40B | +2.6% |
| FY2016 | Dec 31, 2016 | $7.21B | -3.7% |
| FY2015 | Dec 31, 2015 | $7.49B | +0.8% |
| FY2014 | Dec 31, 2014 | $7.44B | +4.0% |
| FY2013 | Dec 31, 2013 | $7.15B | -3.2% |
| FY2012 | Dec 31, 2012 | $7.38B | -0.1% |
| FY2011 | Dec 31, 2011 | $7.39B | +1.8% |
| FY2010 | Dec 31, 2010 | $7.26B | -2.6% |
| FY2009 | Dec 31, 2009 | $7.46B | +2.8% |
| FY2008 | Dec 31, 2008 | $7.25B | +8.1% |
| FY2007 | Dec 31, 2007 | $6.70B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.10B | +10.0% |
| Q2 FY2026 | Jun 30, 2026 | $3.04B | +10.2% |
| Q1 FY2026 | Mar 31, 2026 | $2.90B | +9.2% |
| Q4 FY2025 | Dec 31, 2025 | $2.81B | +7.1% |
| Q3 FY2025 | Sep 30, 2025 | $2.82B | +13.2% |
| Q2 FY2025 | Jun 30, 2025 | $2.76B | +15.2% |
| Q1 FY2025 | Mar 31, 2025 | $2.65B | +12.1% |
| Q4 FY2024 | Dec 31, 2024 | $2.62B | +14.6% |
| Q3 FY2024 | Sep 30, 2024 | $2.49B | +8.4% |
| Q2 FY2024 | Jun 30, 2024 | $2.40B | +2.5% |
| Q1 FY2024 | Mar 31, 2024 | $2.37B | +1.5% |
| Q4 FY2023 | Dec 31, 2023 | $2.29B | -1.9% |
| Q3 FY2023 | Sep 30, 2023 | $2.30B | -7.7% |
| Q2 FY2023 | Jun 30, 2023 | $2.34B | -4.7% |
| Q1 FY2023 | Mar 31, 2023 | $2.33B | -10.7% |
| Q4 FY2022 | Dec 31, 2022 | $2.33B | -15.0% |
| Q3 FY2022 | Sep 30, 2022 | $2.49B | -10.4% |
| Q2 FY2022 | Jun 30, 2022 | $2.45B | -3.8% |
| Q1 FY2022 | Mar 31, 2022 | $2.61B | -4.0% |
| Q4 FY2021 | Dec 31, 2021 | $2.74B | -8.6% |
| Q3 FY2021 | Sep 30, 2021 | $2.77B | -0.4% |
| Q2 FY2021 | Jun 30, 2021 | $2.55B | +39.6% |
| Q1 FY2021 | Mar 31, 2021 | $2.72B | +49.3% |
| Q4 FY2020 | Dec 31, 2020 | $3.00B | +55.9% |
| Q3 FY2020 | Sep 30, 2020 | $2.79B | +42.4% |
| Q2 FY2020 | Jun 30, 2020 | $1.83B | -6.5% |
| Q1 FY2020 | Mar 31, 2020 | $1.82B | -3.6% |
| Q4 FY2019 | Dec 31, 2019 | $1.93B | +4.7% |
| Q3 FY2019 | Sep 30, 2019 | $1.96B | +3.5% |
| Q2 FY2019 | Jun 30, 2019 | $1.95B | +1.8% |
| Q1 FY2019 | Mar 31, 2019 | $1.89B | +0.4% |
| Q4 FY2018 | Dec 31, 2018 | $1.84B | -1.4% |
| Q3 FY2018 | Sep 30, 2018 | $1.89B | +1.8% |
| Q2 FY2018 | Jun 30, 2018 | $1.92B | +3.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.88B | +3.7% |
| Q4 FY2017 | Dec 31, 2017 | $1.87B | +0.2% |
| Q3 FY2017 | Sep 30, 2017 | $1.86B | – |
| Q2 FY2017 | Jun 30, 2017 | $1.86B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.82B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.86B | – |
See a number that looks wrong?